知搜-全球专利检索

  1. 登录
  2. 注册

搜索结果

26 条记录 (耗时 0.026 秒)

    Sn-2 myristate-containing edible oil
    2.
    发明授权
    Sn-2 myristate-containing edible oil 有权
    含Sn-2肉豆蔻酸酯的食用油

    公开(公告)号：US08617634B2

    公开(公告)日：2013-12-31

    申请号：US13060586

    申请日：2009-08-25

    申请人： Daniel Perlman ,  Kenneth C. Hayes

    发明人： Daniel Perlman ,  Kenneth C. Hayes

    IPC分类号： A23D9/00

    CPC分类号： A23D9/02 ,  A23D7/04 ,  A23L33/12 ,  C11C3/10

    摘要： A nutritional fat or oil-based composition for increasing HDL cholesterol, decreasing LDL cholesterol and decreasing the LDL/HDL cholesterol ratio in human plasma is described. The composition can advantageously include at least 1% by weight myristic acid esterified at the sn-2 position in triglyceride molecules, includes between 10% and 40% by weight linoleic acid, and further includes between 30% and 65% by weight oleic acid and between 15% and 40% by weight total saturated fatty acids. The ratio of sn-2 myristic acid to sn-2 palmitic acid is typically greater than 1:1 and the sum of weight percentages for saturated, monounsaturated and polyunsaturated fatty acids equals 100%. In desirable cases, the composition is substantially cholesterol-free.

    摘要翻译： 描述了用于增加HDL胆固醇，降低LDL胆固醇和降低人血浆中LDL / HDL胆固醇比例的营养型油脂或组合物。 组合物可以有利地包括在甘油三酯分子中在sn-2位置酯化的至少1重量％的肉豆蔻酸，包括10重量％至40重量％的亚油酸，并且还包含30重量％至65重量％的油酸和 15％至40％（重量）的总饱和脂肪酸。 sn-2肉豆蔻酸与sn-2棕榈酸的比例通常大于1:1，饱和，单不饱和和多不饱和脂肪酸的重量百分比之和等于100％。 在期望的情况下，组合物基本上不含胆固醇。

    BALANCED SN-2 MYRISTATE-CONTAINING EDIBLE OIL
    4.
    发明申请
    BALANCED SN-2 MYRISTATE-CONTAINING EDIBLE OIL 有权
    平衡SN-2含增容食用油

    公开(公告)号：US20110104326A1

    公开(公告)日：2011-05-05

    申请号：US12197542

    申请日：2008-08-25

    申请人： Daniel Perlman ,  Kenneth C. Hayes

    发明人： Daniel Perlman ,  Kenneth C. Hayes

    IPC分类号： A23D9/00

    CPC分类号： C11C3/10 ,  A23D9/02 ,  A23L33/12

    摘要： A nutritional fat or oil-based composition for increasing HDL cholesterol, decreasing LDL cholesterol and decreasing the LDL/HDL cholesterol ratio in human plasma is described. The composition typically includes at least 1% by weight myristic acid esterified at the sn-2 position in triglyceride molecules, includes between 10% and 40% by weight linoleic acid, and further includes between 30% and 65% by weight oleic acid and between 15% and 40% by weight total saturated fatty acids. The ratio of sn-2 myristic acid to sn-2 palmitic acid is typically greater than 1:1 and the sum of weight percentages for saturated, monounsaturated and polyunsaturated fatty acids equals 100%. In desirable cases, the composition is substantially cholesterol-free.

    摘要翻译： 描述了用于增加HDL胆固醇，降低LDL胆固醇和降低人血浆中LDL / HDL胆固醇比例的营养型油脂或组合物。 组合物通常包含在甘油三酯分子中在sn-2位置酯化的至少1重量％的肉豆蔻酸，包括10重量％至40重量％的亚油酸，并且还包含30重量％至65重量％的油酸之间，以及 15％和40％（重量）的总饱和脂肪酸。 sn-2肉豆蔻酸与sn-2棕榈酸的比例通常大于1:1，饱和，单不饱和和多不饱和脂肪酸的重量百分比之和等于100％。 在期望的情况下，组合物基本上不含胆固醇。

    Hyper-absorption of vitamin E dispersed in milks
    5.
    发明授权
    Hyper-absorption of vitamin E dispersed in milks 有权
    维生素E分散在牛奶中的超吸收

    公开(公告)号：US6156354A

    公开(公告)日：2000-12-05

    申请号：US325258

    申请日：1999-06-03

    申请人： Daniel Perlman ,  Kenneth C. Hayes

    发明人： Daniel Perlman ,  Kenneth C. Hayes

    IPC分类号： A23C9/158 ,  A23C11/04 ,  A23C19/09 ,  A23L33/15 ,  A23L1/302

    CPC分类号： A23C9/158 ,  A23C11/04 ,  A23C19/0921 ,  A23L33/15 ,  A23V2002/00

    摘要： A milk product including a level of vitamin E per serving of said product which can conveniently provide at least 100 IU of vitamin E per day to an individual ingesting the product. The vitamin E is uniformly microdispersed throughout the product, and ingestion of at least 100 IU of vitamin E per day in the product is sufficient to cause the fasting plasma vitamin E/cholesterol ratio in human subjects to be elevated at least 50% above the basal fasting level of vitamin E measured in the same subjects consuming no vitamin E dietary supplements. A method for elevating the plasma vitamin E level at least 50% in human subjects is also described. The method includes ingesting a milk product as described.

    摘要翻译： 一种乳制品，包括每份所述产品的维生素E水平，其可以方便地每天向摄取产品的个体提供至少100IU的维生素E。 维生素E在整个产品中均匀地微分散，并且每天在产品中摄入至少100IU的维生素E足以使人受试者的空腹血浆维生素E /胆固醇比例升高至基础以上至少50％ 维生素E的空腹水平在同一受试者中测量不消耗维生素E膳食补充剂。 还描述了在人受试者中提高血浆维生素E水平至少50％的方法。 该方法包括如上所述摄取牛奶制品。

    Modified fat blends
    6.
    发明授权
    Modified fat blends 失效
    改性脂肪混合物

    公开(公告)号：US5382442A

    公开(公告)日：1995-01-17

    申请号：US883642

    申请日：1992-05-15

    申请人： Daniel Perlman ,  Kenneth C. Hayes

    发明人： Daniel Perlman ,  Kenneth C. Hayes

    IPC分类号： A23D9/007 ,  A21D2/16 ,  A23D7/00 ,  A23D9/00 ,  C11B5/00

    CPC分类号： A21D2/16 ,  A23D7/001 ,  A23D9/00 ,  Y10S426/804 ,  Y10S514/824

    摘要： Blended cholesterol-reduced animal fat and vegetable oil which are combined in a proportion such that the weight ratio of linoleic acid (18:2) content divided by myristic acid (14:2) content is between 2 and 9 inclusive.In addition, cholesterol-reduced animal fat can be blended with cholesterol-reduced fish oil to stabilize the fish oil against air-oxidation at room temperature.

    摘要翻译： 将胆固醇降低的动物脂肪和植物油混合在一起，使得亚油酸（18:2）含量除以肉豆蔻酸（14：2）含量的重量比在2和9之间。 此外，胆固醇降低的动物脂肪可以与胆固醇降低的鱼油混合，以稳定鱼油，防止室温下的空气氧化。

    Balanced sn-2 myristate-containing edible oil
    9.
    发明授权
    Balanced sn-2 myristate-containing edible oil 有权
    平衡的sn-2含肉豆蔻酸的食用油

    公开(公告)号：US08114461B2

    公开(公告)日：2012-02-14

    申请号：US12197542

    申请日：2008-08-25

    申请人： Daniel Perlman ,  Kenneth C. Hayes

    发明人： Daniel Perlman ,  Kenneth C. Hayes

    IPC分类号： A23D9/00 ,  A23D9/02

    CPC分类号： C11C3/10 ,  A23D9/02 ,  A23L33/12

    摘要： A nutritional fat or oil-based composition for increasing HDL cholesterol, decreasing LDL cholesterol and decreasing the LDL/HDL cholesterol ratio in human plasma is described. The composition typically includes at least 1% by weight myristic acid esterified at the sn-2 position in triglyceride molecules, includes between 10% and 40% by weight linoleic acid, and further includes between 30% and 65% by weight oleic acid and between 15% and 40% by weight total saturated fatty acids. The ratio of sn-2 myristic acid to sn-2 palmitic acid is typically greater than 1:1 and the sum of weight percentages for saturated, monounsaturated and polyunsaturated fatty acids equals 100%. In desirable cases, the composition is substantially cholesterol-free.

    摘要翻译： 描述了用于增加HDL胆固醇，降低LDL胆固醇和降低人血浆中LDL / HDL胆固醇比例的营养型油脂或组合物。 组合物通常包含在甘油三酯分子中在sn-2位置酯化的至少1重量％的肉豆蔻酸，包括10重量％至40重量％的亚油酸，并且还包含30重量％至65重量％的油酸之间，以及 15％和40％（重量）的总饱和脂肪酸。 sn-2肉豆蔻酸与sn-2棕榈酸的比例通常大于1:1，饱和，单不饱和和多不饱和脂肪酸的重量百分比之和等于100％。 在期望的情况下，组合物基本上不含胆固醇。

    BALANCED MYRISTATE- AND LAURATE-CONTAINING EDIBLE OIL
    10.
    发明申请
    BALANCED MYRISTATE- AND LAURATE-CONTAINING EDIBLE OIL 审中-公开
    平衡含糖和含莴苣的可食用油

    公开(公告)号：US20110166227A1

    公开(公告)日：2011-07-07

    申请号：US12985441

    申请日：2011-01-06

    申请人： Daniel Perlman ,  Kenneth C. Hayes

    发明人： Daniel Perlman ,  Kenneth C. Hayes

    IPC分类号： A61K31/20 ,  A23D7/00

    CPC分类号： A23D7/001 ,  A23D7/003 ,  A23D9/00 ,  A23K20/158 ,  A23L33/12 ,  A23V2002/00 ,  A61K31/20 ,  A61K31/201 ,  A61K45/06 ,  A61K2300/00 ,  A23V2250/1882 ,  A23V2200/3262 ,  A23V2250/186 ,  A23V2250/1872

    摘要： Nutritional fat or oil-based compositions for increasing HDL cholesterol, decreasing total cholesterol (TC), LDL cholesterol and decreasing the LDL/HDL cholesterol ratio in human plasma are described. The compositions can advantageously include at least 10% of myristic acid and/or lauric acid in which at least 3% of said fatty acid composition is myristic acid and at least 3% is lauric acid; in some cases at least 1% by weight myristic acid and/or lauric acid is esterified at the sn-2 position in triglyceride molecules. The compositions also include between 5% and 40% by weight linoleic acid, and typically further include at least 10% by weight monounsaturated fatty acids and between 15% and 55% by weight total saturated fatty acids. The sum of weight percentages for saturated, monounsaturated and polyunsaturated fatty acids equals 100%. In desirable cases, the composition is substantially cholesterol-free. Also described are fat compositions and diets which are adapted to limit increases in blood triglycerides, total cholesterol, LDL, and VLDL, even in the presence of dietary cholesterol.

    摘要翻译： 描述了用于增加HDL胆固醇，降低总胆固醇（TC），低密度脂蛋白胆固醇和降低人血浆中LDL / HDL胆固醇比例的营养脂肪或油基组合物。 组合物可以有利地包括至少10％的肉豆蔻酸和/或月桂酸，其中至少3％的所述脂肪酸组合物是肉豆蔻酸并且至少3％是月桂酸; 在一些情况下，至少1重量％的肉豆蔻酸和/或月桂酸在甘油三酯分子的sn-2位被酯化。 组合物还包括5重量％至40重量％的亚油酸，并且通常还包括至少10重量％的单不饱和脂肪酸和15重量％至55重量％的总饱和脂肪酸。 饱和，单不饱和和多不饱和脂肪酸的重量百分比之和等于100％。 在期望的情况下，组合物基本上不含胆固醇。 还描述了脂肪组合物和饮食，其适于限制血液甘油三酯，总胆固醇，低密度脂蛋白和VLDL的增加，即使在膳食胆固醇的存在下。